The World Health Organization (WHO) has declared Mpox, formerly known as monkeypox, a global public health emergency of international concern (PHEIC). This decision was made because of the significant rise in Mpox cases around the world, which has become a serious health concern. Here's what you need to know about Mpox and the current situation.

What is Mpox?
Mpox is a viral disease caused by the Orthopoxvirus, which is similar to the virus that causes smallpox. It was first discovered in humans in 1970 in the Democratic Republic of the Congo (DRC). The disease has symptoms similar to smallpox, but they are usually milder. Mpox can affect anyone, but the recent outbreaks have been particularly severe.
Current Situation
- Outbreaks: The recent outbreaks have been especially severe in Africa, with cases reported in more than a dozen countries. A new variant of the virus, known as clade 1b, is spreading rapidly and is more transmissible and deadly. This has raised concerns among health experts.
- Impact: This year alone, over 14,000 cases of Mpox have been reported, along with more than 500 deaths. The rise in cases and fatalities is alarming, and it has prompted the WHO to take action.
WHO's Response
- Declaration: The WHO's declaration of Mpox as a global public health emergency is the highest level of alert under international health law. This move is meant to gather international resources and coordinate efforts to control the outbreak.
- Measures: The WHO is working closely with the affected countries, the Africa Centers for Disease Control and Prevention (CDC), and other partners to create a comprehensive plan to respond to the outbreak. This plan includes increasing surveillance, preparing healthcare systems, and implementing response activities. The WHO has also called for an initial funding requirement of $15 million to support these efforts.
Why This Matters
- Global Concern: The WHO's declaration shows how important it is for countries to work together to stop the spread of Mpox and save lives. The global response needs to be quick and coordinated to prevent the situation from worsening.
- Public Awareness: Raising awareness about Mpox and how it spreads is crucial in controlling the outbreak. People need to know the symptoms and take precautions to protect themselves and others.
The Director-General of WHO, Tedros Adhanom Ghebreyesus, emphasized the importance of international cooperation. He tweeted, "Identification of the first Mpox clade 1b infection in Sweden underscores the need for affected countries to tackle the virus together. We encourage all countries to enhance surveillance, share data, and work to better understand the transmission; share tools like vaccines; and apply lessons learned from prior public health emergencies of international concern in addressing the current outbreak."
Symptoms of Mpox
Mpox presents with symptoms that are similar to smallpox but are generally milder. Here are some common symptoms:
- Early Symptoms: Fever, headache, muscle aches, backache, fatigue, chills, and swollen lymph nodes.
- Rash Development: A rash usually appears 1 to 3 days after the fever. It commonly affects the face, hands, feet, mouth, genitalia, and eyes. The rash goes through several stages: macules (flat, discolored spots), papules (slightly raised lesions), vesicles (bumps filled with clear fluid), pustules (bumps filled with yellowish fluid), and finally scabs.
Duration and Complications
The symptoms of Mpox usually last for 2 to 4 weeks and resolve without treatment. However, in some cases, complications such as bronchopneumonia, sepsis, and encephalitis (inflammation of brain tissue) can occur.
As the world faces this growing health challenge, international cooperation and public awareness are crucial in controlling the spread of Mpox and protecting global health.



Click it and Unblock the Notifications










